Duke Human Vaccine Institute (DHVI) recently won a Vaccine Industry Excellence Award for best academic research team.
The honor, one of 13 awarded by the World Vaccine Congress during its April 2013 meeting in Washington, recognizes individuals, organizations and research teams that have made significant contributions to vaccine development over the past year.
DHVI, led by Barton Haynes, MD, professor of medicine and immunology, was cited for its work leading to new insights into HIV vaccine protection. Last year, DHVI researchers and collaborators with the National Institute of Allergy and Infectious Diseases, the U.S. Military HIV Research Program and the Thailand Ministry of Health published research that shed light on why a promising vaccine fell short of providing broad immunity. The insight will help guide future vaccine development.
Click here to read the full award announcement.